Harry Skip Kiil insider trades: Medtronic (MDT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Harry reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | MDT | ↓ Sell | 1,483 | $93.65 | $139K | Direct | Sep 17, 2026 (1d) |
| Jun 8, 2026 | MDT | ↓ Sell | 4,189 | $80.44 | $337K | Direct | Jun 9, 2026 (1d) |
| Feb 19, 2026 | MDT | ↓ Sell | 52,524 | $97.71 | $5.1M | Direct | Feb 26, 2026 (7d) |
| Sep 3, 2025 | MDT | ↓ Sell | 8,605 | $91.58 | $788K | Direct | Sep 5, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDT insiders
Open-market trades in the last 12 months
About Harry Skip Kiil's insider trades
Harry Skip Kiil is EVP & President Cardiovascular at Medtronic (MDT). Since Sep 3, 2025, Harry has reported no open-market purchases and 4 sales worth $6.4M on SEC Form 4. In the last 12 months: 3 sales ($5.6M).
Their filings also include shares withheld for taxes (3 filings), option exercises (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.